{"name":"Kiora Pharmaceuticals, Inc.","slug":"kiora-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":10780397,"netIncome":-10835154,"cash":24253300,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOUFF0ajF1azVrd0FFZ19kX19LTkp0UHNyOFRMRk1La3E5bnZfSml5bTE2NkI2M1FXQ3ExdTk0ckdMVXhtNEVoWks5SEtENkZ3bW8xc0lEUXowSnJ6LXFRb0FNZXdhRGZ6M01BT2tJb3pvbm1vY1FCSlFtZ2VSSHlkakRPcWxBSjBMMERVZDNMazc4Q1M4NDg2aUROZ1NDcGJMV212X21lR2FUNmNGRE1XNGdrdUlYZw?oc=5","date":"2026-04-08","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga","headline":"12 Health Care Stocks Moving In Wednesday's Intraday Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxOTHNDR2RoWGUwU3lJeHRocVBKaW5WQ09zM2xwWEQzS1JTMndGcFhUcDV0OUpsNTBycEgwVUY3YUJjZ01EOEJJOXdzaER6RF9yQncwc2txQmlGUnktdXBzNXFWVFhpREthbmlabF9vd0JCYTdyYkJnTUxaNkFsbl9tOGt0Qko4TWRmbjh0QnhQa1AtVkRESktTR2lR?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Emerging Growth Patterns Driving Expansion in the Anterior Uveitis Market - openPR.com","headline":"Emerging Growth Patterns Driving Expansion in the Anterior Uveitis Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPOWxGRmhmeVA5N1N3bjlJQlRkLUxNS1JoWXp3YlhDenlHN1Bob250YTBBYlY5cnJhdzY1SEJJaU9TTDkzN2tRdzJKYnpCMGFMQy05SHhtcWg4V3NMbTE0UVZhdjNPdVB4QzJhUG9KWHFOYTJrNU84VW5CQzZHRVZtUVptU1NoWlJm?oc=5","date":"2026-04-07","type":"pipeline","source":"timothysykes.com","summary":"Kiora Pharmaceuticals Inc. Poised for Strategic Expansion Amid Market Challenges - timothysykes.com","headline":"Kiora Pharmaceuticals Inc. Poised for Strategic Expansion Amid Market Challenges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPOGt4RWoyVFpUX3ctSngwcU10M1hRXzgtb0hoQXFvN3A2MTV3Q0lPRHFPb3U1VzBCd1ZGQVlIdXB0d3VmOXM0MHB0UXFoLTdCUUI5dk9LdzVQejNVYllPeTNmcDYwc3dnUU9JbDA3TXZTWm44Z0pyUWhEaTlSdlBvUFFnSXlFeG9NQkE1RzBmQVYta18wb2RwMC1tUVJEaDRaX1pjdXQ3dkxGYnVlTjg3SlZ1OGphUQ?oc=5","date":"2026-04-07","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session","sentiment":"neutral"},{"date":"2026-04-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOT2pIS0R6YWJrdHlLLTY2Z1liTTdRNng5NFctbWJKemtlS2gxY2ZxWmRYOW9DX0EtWXF3LW1BeFRPS3dscDBtVDI5cHdWa0lyNDFGSjdrZ1lRXy1zQld4UWZ2WEZJT0w1VUJ2cGFfNXlBdlFUNjdTY1JnTnRGamhPdWdYTUd3Xy1SWFJoU29fTG1GZkRZYmdOSU9TWjU4Y0cx?oc=5","date":"2026-04-02","type":"pipeline","source":"TMX Newsfile","summary":"Kiora Pharmaceuticals Announces Management Team Changes - TMX Newsfile","headline":"Kiora Pharmaceuticals Announces Management Team Changes","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPX0h2SU40aWs4QWtaSlkzMVJ0Vm9RSTRzMUhScWNUN3F4bXN2WFFPLWtEZEVsRm9ORHBneFFwQjRNei1RT0YweUFTUnhwNkZGMFNXdnJMRnlSMXlONjVlWTkyTW94Qi03RFIwSmp0NmRGc3hZb0VRV1ZudlRVcy1rY2JjQ1JtSUhWOS1BYnVuMVdRaHlHeGVXZXpWaF9ORS14WHQ2VldrRW01ZnlUQmhFN2VHVTk?oc=5","date":"2026-04-02","type":"trial","source":"Stock Titan","summary":"Kiora Pharmaceuticals (NASDAQ: KPRX) details CDO exit and trial progress - Stock Titan","headline":"Kiora Pharmaceuticals (NASDAQ: KPRX) details CDO exit and trial progress","sentiment":"neutral"},{"date":"2026-04-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOeFRzb2ctNFlwaG5abm1HQktueW1wXzd4cEJTblpvd0tOMjFnSlVaNXBoNGpiZy1KbnJJcGdXQkN5SUFjanRMUUo4cHllbUhjSm93TjE2aml5VHo2SFlpT2RZMDVKTW5IcG8tNlh5a1FnXzFqZUItV0w0VVpHZTl5cXFudHdMNmNrZ1lOWEplUThmWGphSjQtUllvbGVLcWhCQUNaZWxpNXU5NC1reTZJSnVUY2swOWFycUlTY3NOZzhRbVNPR19maTZjWVY1Q1JpRWJJMDQ1WDZFMXhqcnNoQ2R1UjdORUhiYzYwN01wNkFhcFNEOXRUUk90VmtuRktuUWNhYnM2dThjTEZwQ3VGSk1vSTBybnpITkZOZjN2TnA?oc=5","date":"2026-03-25","type":"trial","source":"TMX Newsfile","summary":"Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with Two Active Phase 2 Clinical Trials - TMX Newsfile","headline":"Kiora Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Results; Company Advances Retinal Disease Pipeline with ","sentiment":"neutral"},{"date":"2026-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5ITTJNaWRpekM1Sk15U3dpdTAxZWRkY0x4eXFfSUIzX0VlZDVneG9mRHd2Z1lTVkcwa20zSUVUcktib0pQZ1Q4MXlzdl9iY2l1UGZhRXBRWmYzakxFLUMtYkNlYkJGYnZQd09WRUZn?oc=5","date":"2026-03-22","type":"pipeline","source":"Stock Titan","summary":"If You Invested $1,000 in KIORA PHARMACEUTICALS INC (KPRX) - Stock Titan","headline":"If You Invested $1,000 in KIORA PHARMACEUTICALS INC (KPRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQZG1QRlBNT0lfTGRER015WW9FTDJ6aURTV0l5VS1oVTB6NXhQcmN0a0ZkNEpzNzJLNVBVb3I2eTRsYnkzS2ZZbDBKTnFrZEJ6YUlGZmNwbU80WENUeFlCNTRzc0FweEF4Ul9JOUozZmtRSlYxU29wSkw3R1N2MFRwVXN0bkViSmlSN2UxTA?oc=5","date":"2025-12-01","type":"patent","source":"Yahoo Finance","summary":"Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory Compounds - Yahoo Finance","headline":"Kiora Pharmaceuticals Granted U.S. Patent Covering Additional Formulations for the KIO-100 Family of Anti-Inflammatory C","sentiment":"neutral"},{"date":"2025-11-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":0,"period":"2025-12-31"},{"value":16020000,"period":"2024-12-31"},{"value":16020000,"period":"2024-12-31"},{"value":0,"period":"2023-12-31"},{"value":1652520,"period":"2018-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":10780397,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-10835154,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":24253300,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}